Ytterbium-176 is a necessary precursor to lutetium-177, which is used for many cancer therapies, according to the firm. But the world supply of ytterbium-176 has been limited.
Eckert & Ziegler Radiopharma and Atom Mines have developed a new technology that can increase production of the isotope, which will allow for the manufacture of lutetium-177 in larger quantities, the company said.
Copyright © 2022 AuntMinnie.com